Regulatory Update May 15, 2025

Birchtech Supports EPA’s PFAS Compliance Extension, Highlights Strategic Commitment to Water Utilities

Birchtech Supports EPA's PFAS Compliance Extension

Birchtech commends the U.S. Environmental Protection Agency (EPA) for extending the compliance deadline for PFAS (per- and polyfluoroalkyl substances) regulations from 2029 to 2031. This extension provides potable water utilities with critical time to develop and optimize cost-effective, site-specific treatment solutions.

Emerging technologies show strong promise for PFAS removal, but the additional two years will allow utilities to tailor these solutions to their specific water sources and treatment operations. The EPA’s decision reflects a practical approach to implementation and aligns closely with Birchtech strategy to support long-term compliance through innovation and cost efficiency.

“At Birchtech, we invested in two dedicated centers to assist water utilities in evaluating the performance of both virgin and reactivated activated carbon,” said Dr. David Mazyck, Director of Research and Development at Birchtech.

“With reactivated carbon costing roughly half as much as virgin carbon, utilities now have the time and resources to incorporate this cost-saving approach into their compliance planning,” concluded Mazyck.

The anticipated increase in activated carbon usage for PFAS treatment underscores the importance of thermal reactivation. However, thermal reactivation capacity remains limited, especially in regions where demand is expected to rise. Birchtech is actively collaborating with water utilities and engineering consulting firms to develop comprehensive activated carbon solutions, including expanding thermal reactivation capabilities. With decades of experience in activated carbon production and reactivation, Birchtech is uniquely positioned to help utilities meet regulatory requirements while reducing operational costs and environmental impacts.

🔗 Read the EPA’s Full Press Release from May 14, 2025

Dr. David Mazyck, Director of Research and Development

Read more about Dr. David Mazyck.